We propose that upregulating endogenous HO-1 may offer a novel therapeutic approach for treating CE-induced injury and apoptosis by enhancing the antioxidant and anti-apoptotic ability of the epithelium. This evidence concerns the gene HMOX1 and cholesteryl ester measurement.